Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Ur Energy NYSEAMERICAN:URG$1.36 +0.04 (+3.03%) Closing price 04:10 PM EasternExtended Trading$1.38 +0.01 (+1.10%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$524.48 millionConsensus RatingBuyConsensus Price Target$2.57 (+88.7% Upside)Volume7.15 million sharesAverage Volume17.47 million sharesToday's Range$1.31▼$1.38 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Nouveau Monde Graphite NYSE:NMG$1.50 -0.02 (-0.99%) Closing price 03:59 PM EasternExtended Trading$1.48 -0.01 (-0.74%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde GraphiteMarket Capitalization$242.85 millionConsensus RatingBuyConsensus Price Target$4.67 (+212.2% Upside)Volume352,541 sharesAverage Volume812,822 sharesToday's Range$1.49▼$1.533. iBio NASDAQ:IBIO$1.75 +0.02 (+1.16%) Closing price 04:00 PM EasternExtended Trading$1.74 -0.01 (-0.51%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBioMarket Capitalization$85.94 millionConsensus RatingBuyConsensus Price Target$5.00 (+185.7% Upside)Volume439,104 sharesAverage Volume850,001 sharesToday's Range$1.71▼$1.754. Inhibikase Therapeutics NASDAQ:IKT$2.02 +0.09 (+4.87%) Closing price 03:59 PM EasternExtended Trading$1.99 -0.03 (-1.68%) As of 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase TherapeuticsMarket Capitalization$254.82 millionConsensus RatingBuyConsensus Price Target$5.40 (+166.8% Upside)Volume1.52 million sharesAverage Volume773,394 sharesToday's Range$1.92▼$2.055. Stereotaxis NYSEAMERICAN:STXS$1.72 -0.01 (-0.58%) Closing price 04:10 PM EasternExtended Trading$1.76 +0.03 (+2.03%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about StereotaxisMarket Capitalization$169.09 millionConsensus RatingBuyConsensus Price Target$3.88 (+125.3% Upside)Volume369,318 sharesAverage Volume491,147 sharesToday's Range$1.67▼$1.746. Standard Lithium NYSEAMERICAN:SLI$2.75 -0.04 (-1.43%) As of 04:10 PM EasternStandard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. More about Standard LithiumMarket Capitalization$684.78 millionConsensus RatingBuyConsensus Price Target$5.13 (+86.4% Upside)Volume2.23 million sharesAverage Volume1.81 million sharesToday's Range$2.75▼$2.857. Nano-X Imaging NASDAQ:NNOX$1.16 -0.05 (-4.13%) Closing price 04:00 PM EasternExtended Trading$1.17 +0.01 (+0.52%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. More about Nano-X ImagingMarket Capitalization$84.20 millionConsensus RatingBuyConsensus Price Target$5.00 (+331.0% Upside)Volume2.88 million sharesAverage Volume3.65 million sharesToday's Range$1.11▼$1.258. Palisade Bio NASDAQ:PALI$2.09 -0.14 (-6.28%) Closing price 04:00 PM EasternExtended Trading$2.13 +0.04 (+1.91%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade BioMarket Capitalization$387.08 millionConsensus RatingBuyConsensus Price Target$8.83 (+322.6% Upside)Volume5.38 million sharesAverage Volume4.06 million sharesToday's Range$2.05▼$2.299. Peraso NASDAQ:PRSO$0.91 +0.08 (+9.52%) Closing price 04:00 PM EasternExtended Trading$0.89 -0.02 (-2.09%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about PerasoMarket Capitalization$12.24 millionConsensus RatingBuyConsensus Price Target$3.00 (+230.0% Upside)Volume474,237 sharesAverage Volume533,822 sharesToday's Range$0.84▼$0.9210. Ovid Therapeutics NASDAQ:OVID$2.69 -0.03 (-1.10%) Closing price 04:00 PM EasternExtended Trading$2.68 0.00 (-0.19%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$507.66 millionConsensus RatingModerate BuyConsensus Price Target$5.13 (+90.5% Upside)Volume2.97 million sharesAverage Volume3.66 million sharesToday's Range$2.64▼$2.8411. Autolus Therapeutics NASDAQ:AUTL$1.60 -0.05 (-3.03%) Closing price 04:00 PM EasternExtended Trading$1.60 -0.01 (-0.31%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus TherapeuticsMarket Capitalization$439.16 millionConsensus RatingModerate BuyConsensus Price Target$8.75 (+446.9% Upside)Volume1.07 million sharesAverage Volume1.09 million sharesToday's Range$1.59▼$1.6512. Context Therapeutics NASDAQ:CNTX$0.55 -0.02 (-4.02%) Closing price 04:00 PM EasternExtended Trading$0.57 +0.01 (+2.55%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$53.02 millionConsensus RatingModerate BuyConsensus Price Target$6.17 (+1,013.3% Upside)Volume2.64 million sharesAverage Volume3.73 million sharesToday's Range$0.55▼$0.6213. Connect Biopharma NASDAQ:CNTB$2.38 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.40 +0.02 (+0.67%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. More about Connect BiopharmaMarket Capitalization$149.85 millionConsensus RatingModerate BuyConsensus Price Target$7.17 (+201.1% Upside)Volume591,807 sharesAverage Volume431,375 sharesToday's Range$2.37▼$2.4814. Real Brokerage NASDAQ:REAX$1.82 -0.06 (-3.19%) Closing price 04:00 PM EasternExtended Trading$1.84 +0.02 (+1.37%) As of 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Real Brokerage Inc, together with its subsidiaries, operates as a real estate technology company in the United States and Canada. More about Real BrokerageMarket Capitalization$401.38 millionConsensus RatingModerate BuyConsensus Price Target$5.69 (+212.5% Upside)Volume3.00 million sharesAverage Volume3.50 million sharesToday's Range$1.82▼$1.8815. Gold Royalty NYSEAMERICAN:GROY$2.76 +0.01 (+0.36%) Closing price 04:10 PM EasternExtended Trading$2.77 +0.01 (+0.43%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Gold Royalty Corp., a precious metals-focused royalty company, provides financing solutions to the metals and mining industry. More about Gold RoyaltyMarket Capitalization$634.72 millionConsensus RatingModerate BuyConsensus Price Target$5.79 (+109.6% Upside)Volume1.21 million sharesAverage Volume1.97 million sharesToday's Range$2.70▼$2.7716. Compass Therapeutics NASDAQ:CMPX$2.19 +0.03 (+1.39%) Closing price 04:00 PM EasternExtended Trading$2.18 0.00 (-0.23%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass TherapeuticsMarket Capitalization$388.99 millionConsensus RatingModerate BuyConsensus Price Target$12.91 (+489.5% Upside)Volume3.87 million sharesAverage Volume3.52 million sharesToday's Range$2.13▼$2.2917. Tenaya Therapeutics NASDAQ:TNYA$0.74 +0.00 (+0.57%) Closing price 04:00 PM EasternExtended Trading$0.74 +0.00 (+0.26%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$159.47 millionConsensus RatingModerate BuyConsensus Price Target$4.00 (+441.2% Upside)Volume990,370 sharesAverage Volume2.64 million sharesToday's Range$0.72▼$0.7518. Nkarta NASDAQ:NKTX$2.83 -0.02 (-0.70%) Closing price 04:00 PM EasternExtended Trading$2.77 -0.06 (-2.26%) As of 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$203.90 millionConsensus RatingModerate BuyConsensus Price Target$10.75 (+279.9% Upside)Volume460,359 sharesAverage Volume594,209 sharesToday's Range$2.74▼$2.8919. CuriosityStream NASDAQ:CURI$2.66 -0.03 (-1.12%) Closing price 04:00 PM EasternExtended Trading$2.63 -0.03 (-1.13%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStreamMarket Capitalization$158.64 millionConsensus RatingModerate BuyConsensus Price Target$6.00 (+125.6% Upside)Volume308,004 sharesAverage Volume426,923 sharesToday's Range$2.61▼$2.7020. NervGen Pharma NASDAQ:NGEN$2.06 +0.10 (+5.10%) Closing price 04:00 PM EasternExtended Trading$2.06 0.00 (0.00%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen PharmaMarket Capitalization$166.10 millionConsensus RatingModerate BuyConsensus Price Target$18.00 (+773.8% Upside)Volume927,074 sharesAverage Volume467,178 sharesToday's Range$1.91▼$2.1021. Compugen NASDAQ:CGEN$2.14 -0.02 (-0.93%) Closing price 04:00 PM EasternExtended Trading$2.14 +0.00 (+0.23%) As of 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about CompugenMarket Capitalization$204.24 millionP/E Ratio5.78Consensus RatingModerate BuyConsensus Price Target$5.00 (+133.6% Upside)Volume286,183 sharesAverage Volume372,519 shares22. Metagenomi NASDAQ:MGX$1.19 -0.01 (-0.83%) Closing price 04:00 PM EasternExtended Trading$1.18 -0.01 (-0.84%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Metagenomi, Inc, a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. More about MetagenomiMarket Capitalization$45.18 millionConsensus RatingModerate BuyConsensus Price Target$9.00 (+656.3% Upside)Volume231,425 sharesAverage Volume137,539 sharesToday's Range$1.17▼$1.2223. enCore Energy NASDAQ:EU$1.31 -0.02 (-1.50%) Closing price 04:00 PM EasternExtended Trading$1.32 +0.00 (+0.38%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$258.35 millionConsensus RatingModerate BuyConsensus Price Target$3.83 (+192.6% Upside)Volume2.08 million sharesAverage Volume3.89 million sharesToday's Range$1.29▼$1.4024. DeFi Technologies NASDAQ:DEFT$0.51 -0.01 (-2.43%) Closing price 04:00 PM EasternExtended Trading$0.54 +0.02 (+4.82%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DeFi Technologies, Inc engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. More about DeFi TechnologiesMarket Capitalization$204.50 millionP/E Ratio3.76Consensus RatingModerate BuyConsensus Price Target$2.00 (+289.0% Upside)Volume1.51 million sharesAverage Volume4.17 million shares25. Biomea Fusion NASDAQ:BMEA$1.47 +0.08 (+5.76%) Closing price 04:00 PM EasternExtended Trading$1.45 -0.02 (-1.36%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$100.50 millionConsensus RatingModerate BuyConsensus Price Target$8.50 (+478.2% Upside)Volume1.50 million sharesAverage Volume964,942 sharesToday's Range$1.40▼$1.50 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas These 3 Dividend Stocks Could Boost Your Income This July The Quantum Bubble Is Real Enough to Take Seriously Amazon Could Be About to Reap the Rewards of a Software Spending Boom Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks Why Wall Street Still Sees Massive Upside for AeroVironment Stock AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed? Manchester United’s Stock Rally Faces a Test Beyond Old Trafford NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
